# Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens

> **NCT02314325** · PHASE4 · UNKNOWN · sponsor: **St. James's Hospital, Ireland** · enrollment: 20 (estimated)

## Conditions studied

- Severe Haemophilia A

## Interventions

- **DRUG:** ADVATE [Antihemophilic Factor (Recombinant)]
- **DRUG:** ADVATE [Antihemophilic Factor (Recombinant)]

## Key facts

- **NCT ID:** NCT02314325
- **Lead sponsor:** St. James's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2016-05
- **Final completion:** 2016-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314325, "Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02314325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*